These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2661820)

  • 1. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
    Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
    J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
    Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
    J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
    Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
    J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
    Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
    J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of some transition-state inhibitors of human renin.
    Bühlmayer P; Caselli A; Fuhrer W; Göschke R; Rasetti V; Rüeger H; Stanton JL; Criscione L; Wood JM
    J Med Chem; 1988 Sep; 31(9):1839-46. PubMed ID: 3137345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
    TenBrink RE; Pals DT; Harris DW; Johnson GA
    J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
    Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
    J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New renin inhibitors containing novel analogues of statine.
    Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
    J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
    Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
    J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
    Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
    J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of rat renin inhibitory peptides.
    Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E
    J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New inhibitors of human renin that contain novel Leu-Val replacements.
    Luly JR; Yi N; Soderquist J; Stein H; Cohen J; Perun TJ; Plattner JJ
    J Med Chem; 1987 Sep; 30(9):1609-16. PubMed ID: 3305946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel. (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid.
    Thaisrivongs S; Pals DT; Kroll LT; Turner SR; Han FS
    J Med Chem; 1987 Jun; 30(6):976-82. PubMed ID: 3295239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
    Nakagawa T; Akaki J; Satou R; Takaya M; Iwata H; Katsurada A; Nishiuchi K; Ohmura Y; Suzuki F; Nakamura Y
    Biol Chem; 2007 Feb; 388(2):237-46. PubMed ID: 17261087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of potent substrate-analogue inhibitors of canine renin.
    Hui KY; Siragy HM; Haber E
    Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly potent and specific inhibitors of human renin.
    Sham HL; Stein H; Rempel CA; Cohen J; Plattner JJ
    FEBS Lett; 1987 Aug; 220(2):299-301. PubMed ID: 3111889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallographic studies of reduced bond inhibitors complexed with an aspartic proteinase.
    Foundling SI; Cooper J; Watson FE; Pearl LH; Hemmings A; Wood SP; Blundell T; Hallett A; Jones DM; Sueiras J
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S59-68. PubMed ID: 2485065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New inhibitors of human renin tested in vitro and in vivo in the anaesthetized baboon.
    Tree M; Atrash B; Donovan B; Gamble J; Hallett A; Hughes M; Jones DM; Leckie B; Lever AF; Morton JJ
    J Hypertens; 1983 Dec; 1(4):399-403. PubMed ID: 6398331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of human angiotensinogen (1-17) containing one of the putative glycosylation binding sites and its hydrolysis by human renin and porcine pepsin.
    Hirata IY; Boschcov P; Oliveira MC; Juliano MA; Miranda A; Chagas JR; Tsuboi S; Okada Y; Juliano L
    Int J Pept Protein Res; 1991 Oct; 38(4):298-307. PubMed ID: 1797705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.